1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Assessment of Adult Patients with Long COVID Manifestations Suspected as Cardiovascular Shechter et al 2022

Discussion in 'Long Covid research' started by John Mac, Oct 29, 2022.

  1. John Mac

    John Mac Senior Member (Voting Rights)

    Messages:
    926
    Full title:
    Assessment of Adult Patients with Long COVID Manifestations Suspected as Cardiovascular: A Single-Center Experience

    Abstract
    Background: Persistent symptoms affect a subset of coronavirus disease 2019 (COVID-19) survivors. Some of these may be cardiovascular (CV)-related.

    Objective
    : To assess the burden of objective CV morbidity among, and to explore the short-term course experienced by, COVID-19 patients with post-infectious symptomatology suspected as CV.

    Methods
    : This was a single-center, retrospective analysis of consecutive adult patients with new-onset symptoms believed to be CV following recovery from COVID-19, who had been assessed at a dedicated 'Cardio'-COVID clinic between June 2020 and June 2021. All participants were followed for 1 year for symptomatic course and the occurrence of new CV diagnoses and major adverse cardiovascular events (MACE).

    Results
    : A total of 96 patients (median age 54 (IQR, 44-64) years, 52 (54%) females) were included in the final analysis. Initial visits occurred within a median of 142 days after the diagnosis of acute COVID.
    Nearly all (99%) patients experienced a symptomatic acute illness, which was graded as severe in 26 (27%) cases according to the National Institutes of Health (NIH) criteria.
    Long-COVID symptoms included mainly dyspnea and fatigue.
    While the initial work-up was mostly normal, 45% of the 11 cardiac magnetic resonance studies performed revealed pathologies.
    New CV diagnoses were made in nine (9%) patients and mainly included myocarditis that later resolved. An abnormal spirometry was the only variable associated with these.
    No MACE were recorded.
    Fifty-two (54%) participants felt that their symptoms improved. No association was found between CV morbidity and symptomatic course.

    Conclusions
    : In our experience, long-COVID symptoms of presumed CV origin signified actual CV disease in a minority of patients who, irrespective of the final diagnosis, faced a fair 1-year prognosis.

    https://pubmed.ncbi.nlm.nih.gov/36294444/
     
    Peter Trewhitt and RedFox like this.

Share This Page